<DOC>
	<DOCNO>NCT00773890</DOCNO>
	<brief_summary>This study design assess safety , tolerability , activity TRF-1101 microvascular blood flow , vascular endothelial injury , vasoocclusive pain associate sickle cell disease .</brief_summary>
	<brief_title>TRF-1101 Assessment Sickle Cell Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Be 18 year age old time informed consent ; Have diagnosis homozygous sickle cell anemia sickle cellbeta° thalassemia ; Have 2 10 document pain crisis past year ( pain crisis define visit medical clinic , Emergency Department hospital , bedridden require constant analgesia home least three day , threeday interruption life 's activity [ i.e. , school , work , planned leisure activity ] pain ) ; If female child bear potential , negative serum urine pregnancy test use effective birthcontrol method history reliability individual patient ( use mifepristone allow ) ; Be properly informed nature risk clinical investigation , willing able comply clinical investigationrelated procedure assessment , sign Institutional Review Board ( IRB ) approve Informed Consent Form prior enter clinical investigation . Have history abnormal bleeding , stroke , moya moya vascular malformation , contraindication anticoagulation ; Be currently take anticoagulant thrombolytic medication ; Be currently take endothelin receptor antagonist , e.g. , bosentan ( Tracleer® ) ; Have know sensitivity allergy heparin relate drug ; Have history thrombocytopenia ( platelet count &lt; 100 x 103/mm3 ) induce heparin related drug ; Have few 2 document pain crisis past year ; Have pain crisis within one month screen randomization ; If currently recently discontinue hydroxyurea treatment , initiate discontinue treatment change regimen within past 6 month ; Have transfusion within last 120 day HbA % &gt; 15 % prior transfusion ; Creatinine level &gt; 1.53 mg/dL ( 135 umol/L ) ; ALT level ≥ 3 time normal ; Platelet count &lt; 100 x 103/mm3 ; INR &gt; 2.0 ; Be unable tolerate oral medication ; Have unreliable venous access ; Be noncompliant regular care ; Have positive pregnancy test , currently lactate , try become pregnant ; Have participation investigational drug medical device study within previous 30 day ; Have condition circumstance opinion Investigator make patient poor candidate participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>